持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/12/06 | 8,180 | 8,250 | 8,070 | 8,090 | -60 | -0.7% | 32,900 |
| 2017/12/05 | 8,010 | 8,190 | 8,010 | 8,150 | +120 | +1.5% | 33,200 |
| 2017/12/04 | 8,170 | 8,200 | 8,010 | 8,030 | -60 | -0.7% | 42,400 |
| 2017/12/01 | 8,160 | 8,170 | 8,080 | 8,090 | -30 | -0.4% | 27,200 |
| 2017/11/30 | 8,020 | 8,150 | 7,980 | 8,120 | +100 | +1.2% | 40,900 |
| 2017/11/29 | 7,960 | 8,040 | 7,960 | 8,020 | +80 | +1% | 22,300 |
| 2017/11/28 | 7,920 | 7,990 | 7,910 | 7,940 | +60 | +0.8% | 31,600 |
| 2017/11/27 | 7,930 | 7,950 | 7,870 | 7,880 | +20 | +0.3% | 30,900 |
| 2017/11/24 | 7,930 | 7,950 | 7,860 | 7,860 | -160 | -2% | 47,500 |
| 2017/11/22 | 8,150 | 8,160 | 8,010 | 8,020 | -80 | -1% | 25,100 |
| 2017/11/21 | 7,980 | 8,150 | 7,980 | 8,100 | +130 | +1.6% | 30,000 |
| 2017/11/20 | 7,950 | 8,010 | 7,920 | 7,970 | -70 | -0.9% | 46,500 |
| 2017/11/17 | 8,170 | 8,240 | 8,030 | 8,040 | -150 | -1.8% | 62,300 |
| 2017/11/16 | 8,050 | 8,190 | 8,040 | 8,190 | +100 | +1.2% | 18,800 |
| 2017/11/15 | 8,140 | 8,200 | 8,080 | 8,090 | -150 | -1.8% | 35,600 |
| 2017/11/14 | 8,220 | 8,310 | 8,210 | 8,240 | +10 | +0.1% | 27,200 |
| 2017/11/13 | 8,270 | 8,270 | 8,200 | 8,230 | -10 | -0.1% | 11,500 |
| 2017/11/10 | 8,200 | 8,250 | 8,170 | 8,240 | -70 | -0.8% | 23,800 |
| 2017/11/09 | 8,320 | 8,390 | 8,260 | 8,310 | -10 | -0.1% | 44,300 |
| 2017/11/08 | 8,260 | 8,350 | 8,220 | 8,320 | +30 | +0.4% | 38,100 |
| 2017/11/07 | 8,240 | 8,300 | 8,170 | 8,290 | +90 | +1.1% | 30,500 |
| 2017/11/06 | 8,210 | 8,230 | 8,170 | 8,200 | -10 | -0.1% | 20,900 |
| 2017/11/02 | 8,300 | 8,300 | 8,170 | 8,210 | -90 | -1.1% | 31,000 |
| 2017/11/01 | 8,280 | 8,320 | 8,240 | 8,300 | +20 | +0.2% | 54,200 |
| 2017/10/31 | 8,790 | 8,790 | 8,220 | 8,280 | -550 | -6.2% | 109,400 |
| 2017/10/30 | 8,880 | 8,990 | 8,660 | 8,830 | +30 | +0.3% | 95,900 |
| 2017/10/27 | 8,690 | 8,830 | 8,690 | 8,800 | +80 | +0.9% | 22,700 |
| 2017/10/26 | 8,780 | 8,780 | 8,720 | 8,720 | -10 | -0.1% | 11,500 |
| 2017/10/25 | 8,820 | 8,830 | 8,710 | 8,730 | -140 | -1.6% | 29,000 |
| 2017/10/24 | 8,790 | 8,880 | 8,740 | 8,870 | +80 | +0.9% | 27,500 |
| 2017/10/23 | 8,880 | 8,880 | 8,770 | 8,790 | +20 | +0.2% | 20,000 |
| 2017/10/20 | 8,670 | 8,780 | 8,650 | 8,770 | +130 | +1.5% | 41,100 |
| 2017/10/19 | 8,650 | 8,650 | 8,600 | 8,640 | -20 | -0.2% | 20,000 |
| 2017/10/18 | 8,510 | 8,670 | 8,510 | 8,660 | +140 | +1.6% | 27,600 |
| 2017/10/17 | 8,490 | 8,540 | 8,410 | 8,520 | +50 | +0.6% | 29,800 |
| 2017/10/16 | 8,390 | 8,480 | 8,380 | 8,470 | +30 | +0.4% | 23,200 |
| 2017/10/13 | 8,380 | 8,450 | 8,380 | 8,440 | +50 | +0.6% | 26,700 |
| 2017/10/12 | 8,420 | 8,420 | 8,370 | 8,390 | +10 | +0.1% | 9,300 |
| 2017/10/11 | 8,350 | 8,420 | 8,320 | 8,380 | -30 | -0.4% | 31,000 |
| 2017/10/10 | 8,300 | 8,430 | 8,290 | 8,410 | +100 | +1.2% | 38,800 |
| 2017/10/06 | 8,230 | 8,340 | 8,190 | 8,310 | +80 | +1% | 28,300 |
| 2017/10/05 | 8,200 | 8,250 | 8,190 | 8,230 | -20 | -0.2% | 19,400 |
| 2017/10/04 | 8,290 | 8,330 | 8,200 | 8,250 | -60 | -0.7% | 26,800 |
| 2017/10/03 | 8,320 | 8,320 | 8,220 | 8,310 | +50 | +0.6% | 27,200 |
| 2017/10/02 | 8,360 | 8,360 | 8,240 | 8,260 | -10 | -0.1% | 22,800 |
| 2017/09/29 | 8,250 | 8,270 | 8,220 | 8,270 | -10 | -0.1% | 18,000 |
| 2017/09/28 | 8,200 | 8,300 | 8,150 | 8,280 | +60 | +0.7% | 25,500 |
| 2017/09/27 | 8,300 | 8,320 | 8,190 | 8,220 | -130 | -1.6% | 25,500 |
| 2017/09/26 | 8,290 | 8,370 | 8,270 | 8,350 | +80 | +1% | 35,900 |
| 2017/09/25 | 8,190 | 8,280 | 8,190 | 8,270 | +40 | +0.5% | 24,500 |
1701～
1750
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
